{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:24:39Z","timestamp":1762521879009,"version":"3.37.3"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,4,12]],"date-time":"2016-04-12T00:00:00Z","timestamp":1460419200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,4,12]],"date-time":"2016-04-12T00:00:00Z","timestamp":1460419200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000027","name":"NIAAA","doi-asserted-by":"crossref","award":["1U01AA021908-01","P30 DK34987"],"award-info":[{"award-number":["1U01AA021908-01","P30 DK34987"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1007\/s12072-015-9701-6","type":"journal-article","created":{"date-parts":[[2016,4,14]],"date-time":"2016-04-14T11:46:28Z","timestamp":1460634388000},"page":"538-552","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["New therapeutic targets in alcoholic hepatitis"],"prefix":"10.1007","volume":"10","author":[{"given":"Diana","family":"Arsene","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar","family":"Farooq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramon","family":"Bataller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,4,12]]},"reference":[{"key":"9701_CR1","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/hep.23258","volume":"51","author":"RS O\u2019Shea","year":"2010","unstructured":"O\u2019Shea RS, et al. Alcoholic liver disease. Hepatology 2010;51:307\u2013328","journal-title":"Hepatology"},{"key":"9701_CR2","unstructured":"World Health Organization. Alcohol Fact Sheet. WHO Media Center Fact Sheets 2015 http:\/\/www.who.int\/mediacentre\/factsheets\/fs349\/en\/"},{"key":"9701_CR3","unstructured":"NIAAA. Alcohol Facts and Statistics. http:\/\/www.niaaa.nih.gov\/alcohol-health\/overview-alcohol-consumption\/alcohol-facts-and-statistics"},{"issue":"1 Suppl","key":"9701_CR4","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1016\/j.jhep.2015.03.006","volume":"62","author":"P Mathurin","year":"2015","unstructured":"Mathurin P, Bataller R. Trends in the management and burden of alcoholic liver disease. J Hepatol 2015;62(1 Suppl):S38\u2013S46","journal-title":"J Hepatol"},{"key":"9701_CR5","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.jhep.2010.07.016","volume":"54","author":"TD Sandahl","year":"2011","unstructured":"Sandahl TD, Jepsen P, Thomsen KL, Vilstrup H. Incidence and mortality of alcoholic hepatitis in Denmark 1999\u20132008: a nationwide population based cohort study. J Hepatol 2011;54:760\u2013764","journal-title":"J Hepatol"},{"key":"9701_CR6","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1055\/s-0029-1214373","volume":"29","author":"H Tsukamoto","year":"2009","unstructured":"Tsukamoto H, et al. \u201cSecond hit\u2019\u2019 models of alcoholic liver disease. Semin Liver Dis 2009;29:178\u2013187","journal-title":"Semin Liver Dis"},{"key":"9701_CR7","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1055\/s-2006-960170","volume":"27","author":"NM de Wilfred Alwis","year":"2007","unstructured":"de Wilfred Alwis NM, Day CP. Genetics of alcoholic liver disease and nonalcoholic fatty liver disease. Semin Liver Dis 2007;27:44\u201354","journal-title":"Semin Liver Dis"},{"key":"9701_CR8","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/hep.21023","volume":"43","author":"E Zintzaras","year":"2006","unstructured":"Zintzaras E, et al. Do alcohol-metabolizing enzyme gene polymorphisms increase the risk of alcoholism and alcoholic liver disease? Hepatology. 2006;43:352\u2013361","journal-title":"Hepatology"},{"key":"9701_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/ng.488","volume":"42","author":"C Tian","year":"2010","unstructured":"Tian C, et al. Variant in PNPLA3 is associated with alcoholic liver disease. Nat Genet 2010;42:21\u201323","journal-title":"Nat Genet"},{"key":"9701_CR10","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1136\/gutjnl-2011-301239","volume":"61","author":"F Stickel","year":"2012","unstructured":"Stickel F, Hampe J. Genetic determinants of alcoholic liver disease. Gut. 2012;61:150\u2013159","journal-title":"Gut"},{"key":"9701_CR11","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.jhep.2011.01.028","volume":"55","author":"E Tr\u00e9po","year":"2011","unstructured":"Tr\u00e9po E, et al. Common polymorphism in the PNPLA3\/adiponutrin gene confers higher risk of cirrhosis and liver damage in alcoholic liver disease. J Hepatol 2011;55:906\u2013912","journal-title":"J Hepatol"},{"key":"9701_CR12","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1093\/aje\/kwp236","volume":"170","author":"M Marcos","year":"2009","unstructured":"Marcos M, et al. Tumor necrosis factor polymorphisms and alcoholic liver disease: a HuGE review and meta-analysis. Am J Epidemiol 2009;170:948\u2013956","journal-title":"Am J Epidemiol"},{"key":"9701_CR13","first-page":"1183","volume":"25","author":"T Zeng","year":"2013","unstructured":"Zeng T, et al. Association between CD14-159C>T polymorphisms and the risk for alcoholic liver disease: a meta-analysis. Eur J Gastroenterol Hepatol 2013;25:1183\u20131189","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"9701_CR14","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/nrgastro.2011.134","volume":"8","author":"J Altamirano","year":"2011","unstructured":"Altamirano J, Bataller R. Alcoholic liver disease: pathogenesis and new targets for therapy. Nat Rev Gastroenterol Hepatol 2011;8:491\u2013501","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"9701_CR15","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.gastrohep.2014.02.001","volume":"37","author":"J Casanova","year":"2014","unstructured":"Casanova J, Bataller R. Alcoholic hepatitis: prognosis and treatment. Gastroenterol Hepatol 2014;37:262\u2013268 Epub 2014 Mar 20","journal-title":"Gastroenterol Hepatol"},{"key":"9701_CR16","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1111\/tri.12123","volume":"26","author":"AK Singal","year":"2013","unstructured":"Singal AK, et al. Nutritional status of patients with alcoholic cirrhosis undergoing liver transplantation: time trends and impact on survival. Transpl Int 2013;26:788\u2013794","journal-title":"Transpl Int"},{"key":"9701_CR17","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1111\/j.1572-0241.2002.05826.x","volume":"97","author":"A Rambaldi","year":"2002","unstructured":"Rambaldi A, et al. Anabolic-androgenic steroids for alcoholic liver disease: a Cochrane review. Am J Gastroenterol 2002;97:1674\u20131681","journal-title":"Am J Gastroenterol"},{"key":"9701_CR18","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1053\/jhep.2000.8627","volume":"32","author":"E Cabr\u00e9","year":"2000","unstructured":"Cabr\u00e9 E, et al. Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: a multicenter randomized trial. Hepatology. 2000;32:36\u201342","journal-title":"Hepatology"},{"key":"9701_CR19","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1111\/apt.12654","volume":"39","author":"V Papastergiou","year":"2014","unstructured":"Papastergiou V, et al. Nine scoring models for short-term mortality in alcoholic hepatitis: cross-validation in a biopsy-proven cohort. Aliment Pharmacol Ther 2014;39:721\u2013732","journal-title":"Aliment Pharmacol Ther"},{"key":"9701_CR20","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1053\/j.gastro.2015.04.044","volume":"149","author":"A Louvet","year":"2015","unstructured":"Louvet A, et al. Combining data from liver disease scoring systems better predicts outcomes of patients with alcoholic hepatitis. Gastroenterology. 2015;149:398\u2013406.e8 Epub 2015 Apr 29","journal-title":"Gastroenterology"},{"key":"9701_CR21","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.jhep.2012.04.004","volume":"57","author":"European Association for the Study of Liver","year":"2012","unstructured":"European Association for the Study of Liver. EASL clinical practical guidelines: management of alcoholic liver disease. J Hepatol 2012;57:399\u2013420","journal-title":"J Hepatol"},{"key":"9701_CR22","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1136\/gut.2010.224097","volume":"60","author":"P Mathurin","year":"2011","unstructured":"Mathurin P, et al. Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data. Gut. 2011;60:255\u2013260","journal-title":"Gut"},{"key":"9701_CR23","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1002\/hep.21607","volume":"45","author":"A Louvet","year":"2007","unstructured":"Louvet A, et al. The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids. Hepatology. 2007;45:1348\u20131354","journal-title":"Hepatology"},{"key":"9701_CR24","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/1745-6215-14-262","volume":"14","author":"E Forrest","year":"2013","unstructured":"Forrest E, et al. Steroids or pentoxifylline for alcoholic hepatitis (STOPAH): study protocol for a randomised controlled trial. Trials. 2013;14:262","journal-title":"Trials"},{"key":"9701_CR25","first-page":"1","volume":"4","author":"K Whitfield","year":"2009","unstructured":"Whitfield K, et al. Pentoxifylline for alcoholic hepatitis. Cochrane Database Syst Rev 2009;4:1\u201346","journal-title":"Cochrane Database Syst Rev"},{"key":"9701_CR26","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1053\/j.gastro.2006.12.036","volume":"132","author":"J Colmenero","year":"2007","unstructured":"Colmenero J, Bataller R, Sancho-Bru P, et al. Hepatic expression of candidate genes in patients with alcoholic hepatitis: correlation with disease severity. Gastroenterology. 2007;132:687\u2013697","journal-title":"Gastroenterology"},{"key":"9701_CR27","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1053\/j.gastro.2009.01.056","volume":"136","author":"M Dominguez","year":"2009","unstructured":"Dominguez M, Miquel R, Colmenero J, et al. Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis. Gastroenterology. 2009;136:1639\u20131650","journal-title":"Gastroenterology"},{"key":"9701_CR28","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1053\/j.gastro.2008.08.057","volume":"135","author":"NC Boetticher","year":"2008","unstructured":"Boetticher NC, Peine CJ, Kwo P, Abrams GA, Patel T, Aqel B, et al. A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis. Gastroenterology. 2008;135:1953\u20131960","journal-title":"Gastroenterology"},{"key":"9701_CR29","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1056\/NEJMoa1101214","volume":"365","author":"E Nguyen-Khac","year":"2011","unstructured":"Nguyen-Khac E, Thevenot T, Piquet MA, et al. Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis. N Engl J Med 2011;365:1781\u20131789","journal-title":"N Engl J Med"},{"key":"9701_CR30","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.bpg.2010.07.003","volume":"24","author":"F Stickel","year":"2010","unstructured":"Stickel F, Seitz HK. Alcoholic steatohepatitis. Best Pract Res Clin Gastroenterol 2010;24:683\u2013693","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"9701_CR31","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.jhep.2009.12.021","volume":"52","author":"P Dureja","year":"2010","unstructured":"Dureja P, Lucey MR. The place of liver transplantation in the treatment of severe alcoholic hepatitis. J Hepatol 2010;52:759\u2013764","journal-title":"J Hepatol"},{"key":"9701_CR32","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1056\/NEJMoa1105703","volume":"365","author":"P Mathurin","year":"2011","unstructured":"Mathurin P, Moreno C, Samuel D, Dumortier J, Salleron J, Durand F, et al. Early liver transplantation for severe alcoholic hepatitis. N Engl J Med 2011;365:1790\u20131800","journal-title":"N Engl J Med"},{"key":"9701_CR33","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/j.1600-6143.2009.02869.x","volume":"10","author":"P Burra","year":"2010","unstructured":"Burra P, Senzolo M, Adam R, et al. Liver transplantation for alcoholic liver disease in Europe: a study from the ELTR (European Liver Transplant Registry). Am J Transplant 2010;10:138\u2013148","journal-title":"Am J Transplant"},{"key":"9701_CR34","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/nprot.2013.032","volume":"8","author":"A Bertola","year":"2013","unstructured":"Bertola A, Mathews S, Ki SH, Wang H, Gao B. Mouse model of chronic and binge ethanol feeding (the NIAAA model). Nat Protoc 2013;8:627\u2013637","journal-title":"Nat Protoc"},{"key":"9701_CR35","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/hep.27383","volume":"61","author":"R Lazaro","year":"2015","unstructured":"Lazaro R, Wu R, Lee S, Zhu NL, Chen CL, French SW, et al. Osteopontin deficiency does not prevent but promotes alcoholic neutrophilic hepatitis in mice. Hepatology. 2015;61:129\u2013140","journal-title":"Hepatology"},{"key":"9701_CR36","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1055\/s-0029-1214373","volume":"29","author":"H Tsukamoto","year":"2009","unstructured":"Tsukamoto H, Machida K, Dynnyk A, Mkrtchyan H. \u201cSecond hit\u201d models of alcoholic liver disease. Semin Liver Dis 2009;29:178\u2013187","journal-title":"Semin Liver Dis"},{"key":"9701_CR37","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/nrgastro.2011.134","volume":"8","author":"J Altamirano","year":"2011","unstructured":"Altamirano J, Bataller R. Alcoholic liver disease: pathogenesis and new targets for therapy. Nat Rev Gastroenterol Hepatol 2011;8:491\u2013501","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"9701_CR38","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0022-2275(20)40613-3","volume":"20","author":"E Baraona","year":"1979","unstructured":"Baraona E, Lieber CS. Effects of ethanol on lipid metabolism. J Lipid Res 1979;20:289\u2013315","journal-title":"J Lipid Res"},{"key":"9701_CR39","doi-asserted-by":"publisher","first-page":"561","DOI":"10.2174\/1566524033479537","volume":"3","author":"S Yu","year":"2003","unstructured":"Yu S, Rao S, Reddy JK. Peroxisome proliferator-activated receptors, fatty acid oxidation, steatohepatitis and hepatocarcinogenesis. Curr Mol Med 2003;3:561\u2013572","journal-title":"Curr Mol Med"},{"key":"9701_CR40","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1002\/hep.24148","volume":"53","author":"M Wagner","year":"2011","unstructured":"Wagner M, Zollner G, Trauner M. Nuclear receptors in liver disease. Hepatology. 2011;53:1023\u20131034","journal-title":"Hepatology"},{"key":"9701_CR41","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1002\/hep.22222","volume":"47","author":"Y Lu","year":"2008","unstructured":"Lu Y, Zhuge J, Wang X, et al. Cytochrome P450 2E1 contributes to ethanol-induced fatty liver in mice. Hepatology. 2008;47:1483\u20131494","journal-title":"Hepatology"},{"key":"9701_CR42","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1002\/hep.20821","volume":"42","author":"M You","year":"2005","unstructured":"You M, Considine RV, Leone TC, et al. Role of adiponectin in the protective action of dietary saturated fat against alcoholic fatty liver in mice. Hepatology. 2005;42:568\u2013577","journal-title":"Hepatology"},{"key":"9701_CR43","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1002\/hep.23090","volume":"50","author":"X Kang","year":"2009","unstructured":"Kang X, Zhong W, Liu J, et al. Zinc supplementation reverses alcohol-induced steatosis in mice through reactivating hepatocyte nuclear factor-4alpha and peroxisome proliferator-activated receptor-alpha. Hepatology. 2009;50:1241\u20131250","journal-title":"Hepatology"},{"key":"9701_CR44","doi-asserted-by":"publisher","first-page":"29342","DOI":"10.1074\/jbc.M202411200","volume":"277","author":"M You","year":"2002","unstructured":"You M, Fischer M, Deeg MA, et al. Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP). J Biol Chem 2002;277:29342\u201329347","journal-title":"J Biol Chem"},{"key":"9701_CR45","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/hep.23382","volume":"51","author":"F Esfandiari","year":"2010","unstructured":"Esfandiari F, Medici V, Wong DH, et al. Epigenetic regulation of hepatic endoplasmic reticulum stress pathways in the ethanol-fed cystathionine beta synthase-deficient mouse. Hepatology. 2010;51:932\u2013941","journal-title":"Hepatology"},{"key":"9701_CR46","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1172\/JCI37409","volume":"119","author":"Z Peng","year":"2009","unstructured":"Peng Z, Borea PA, Varani K, et al. Adenosine signaling contributes to ethanol-induced fatty liver in mice. J Clin Invest 2009;119:582\u2013594","journal-title":"J Clin Invest"},{"key":"9701_CR47","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.cmet.2007.12.007","volume":"7","author":"WI Jeong","year":"2008","unstructured":"Jeong WI, Osei-Hyiaman D, Park O, et al. Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver. Cell Metab 2008;7:227\u2013235","journal-title":"Cell Metab"},{"key":"9701_CR48","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1002\/hep.24077","volume":"53","author":"J Tam","year":"2011","unstructured":"Tam J, Liu J, Mukhopadhyay B, et al. Endocannabinoids in liver disease. Hepatology. 2011;53:346\u2013355","journal-title":"Hepatology"},{"key":"9701_CR49","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1053\/j.gastro.2004.09.049","volume":"127","author":"M You","year":"2004","unstructured":"You M, Matsumoto M, Pacold CM, et al. The role of AMP-activated protein kinase in the action of ethanol in the liver. Gastroenterology. 2004;127:1798\u20131808","journal-title":"Gastroenterology"},{"key":"9701_CR50","doi-asserted-by":"publisher","first-page":"G892","DOI":"10.1152\/ajpgi.00575.2007","volume":"294","author":"M You","year":"2008","unstructured":"You M, Liang X, Ajmo JM, et al. Involvement of mammalian sirtuin 1 in the action of ethanol in the liver. Am J Physiol Gastrointest Liver Physiol 2008;294:G892\u2013G898","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"9701_CR51","doi-asserted-by":"publisher","first-page":"850","DOI":"10.3181\/0902-MR-61","volume":"2009","author":"MRC You","year":"2009","unstructured":"You MRC. Adiponectin: a key adipokine in alcoholic fatty liver. Exp Biol Med (Maywood) 2009;2009:850\u2013859","journal-title":"Exp Biol Med (Maywood)"},{"key":"9701_CR52","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.jhep.2010.12.034","volume":"55","author":"J Xu","year":"2011","unstructured":"Xu J, Lai KK, Verlinsky A, Lugea A, French SW, Cooper MP, et al. Synergistic steatohepatitis by moderate obesity and alcohol in mice despite increased adiponectin and p-AMPK. J Hepatol 2011;55:673\u2013682","journal-title":"J Hepatol"},{"key":"9701_CR53","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/j.1748-1716.2009.01970.x","volume":"196","author":"BGB Viollet","year":"2009","unstructured":"Viollet BGB, Leclerc J, H\u00e9brard S, Lantier L, Mounier R, Andreelli F, Foretz M. AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives. Acta Physiol (Oxf) 2009;196:81\u201398","journal-title":"Acta Physiol (Oxf)"},{"key":"9701_CR54","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.cmet.2011.03.009","volume":"13","author":"Y Li","year":"2011","unstructured":"Li Y, Xu S, Mihaylova MM, et al. AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab 2011;13:376\u2013388","journal-title":"Cell Metab"},{"key":"9701_CR55","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1053\/j.gastro.2011.04.038","volume":"140","author":"MJ Czaja","year":"2011","unstructured":"Czaja MJ. Functions of autophagy in hepatic and pancreatic physiology and disease. Gastroenterology. 2011;140:1895\u20131908","journal-title":"Gastroenterology"},{"key":"9701_CR56","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.3748\/wjg.15.1178","volume":"15","author":"TM Donohue Jr","year":"2009","unstructured":"Donohue TM Jr. Autophagy and ethanol-induced liver injury. World J Gastroenterol 2009;15:1178\u20131185","journal-title":"World J Gastroenterol"},{"key":"9701_CR57","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.bbrc.2010.09.127","volume":"402","author":"D Wu","year":"2010","unstructured":"Wu D, Wang X, Zhou R, et al. CYP2E1 enhances ethanol-induced lipid accumulation but impairs autophagy in HepG2 E47 cells. Biochem Biophys Res Commun 2010;402:116\u2013122","journal-title":"Biochem Biophys Res Commun"},{"key":"9701_CR58","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1053\/j.gastro.2010.07.041","volume":"139","author":"WX Ding","year":"2010","unstructured":"Ding WX, Li M, Chen X, et al. Autophagy reduces acute ethanol-induced hepatotoxicity and steatosis in mice. Gastroenterology. 2010;139:1740\u20131752","journal-title":"Gastroenterology"},{"key":"9701_CR59","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.5858\/2004-128-1230-TIOFIA","volume":"128","author":"A Chedid","year":"2004","unstructured":"Chedid A, Arain S, et al. The immunology of fibrogenesis in alcoholic liver disease. Arch Pathol Lab Med 2004;128:1230\u20131238","journal-title":"Arch Pathol Lab Med"},{"key":"9701_CR60","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.4049\/jimmunol.181.5.3049","volume":"181","author":"XJ Zhao","year":"2008","unstructured":"Zhao XJ, Dong Q, Bindas J, et al. TRIF and IRF-3 binding to the TNF promoter results in macrophage TNF dysregulation and steatosis induced by chronic ethanol. J Immunol 2008;181:3049\u20133056","journal-title":"J Immunol"},{"key":"9701_CR61","doi-asserted-by":"crossref","unstructured":"Petrasek J, Mandrekar P, Szabo G. Toll-like receptors in the pathogenesis of alcoholic liver disease. Gastroenterol Res Pract 2010;2010","DOI":"10.1155\/2010\/710381"},{"key":"9701_CR62","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/S0016-5085(99)70354-9","volume":"117","author":"M Yin","year":"1999","unstructured":"Yin M, Wheeler MD, Kono H, Bradford BU, Gallucci RM, Luster MI, et al. Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice. Gastroenterology. 1999;117:942\u2013952","journal-title":"Gastroenterology"},{"key":"9701_CR63","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1002\/hep.22470","volume":"48","author":"I Hritz","year":"2008","unstructured":"Hritz I, Mandrekar P, Velayudham A, et al. The critical role of toll-like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88. Hepatology. 2008;48:1224\u20131231","journal-title":"Hepatology"},{"key":"9701_CR64","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1053\/j.gastro.2007.01.053","volume":"132","author":"MT Pritchard","year":"2007","unstructured":"Pritchard MT, McMullen MR, Stavitsky AB, et al. Differential contributions of C3, C5, and decay-accelerating factor to ethanol-induced fatty liver in mice. Gastroenterology. 2007;132:1117\u20131126","journal-title":"Gastroenterology"},{"key":"9701_CR65","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1002\/hep.22776","volume":"49","author":"S Roychowdhury","year":"2009","unstructured":"Roychowdhury S, McMullen MR, Pritchard MT, et al. An early complement-dependent and TLR-4-independent phase in the pathogenesis of ethanol-induced liver injury in mice. Hepatology. 2009;49:1326\u20131334","journal-title":"Hepatology"},{"key":"9701_CR66","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1053\/j.gastro.2008.01.016","volume":"134","author":"N Horiguchi","year":"2008","unstructured":"Horiguchi N, Wang L, Mukhopadhyay P, et al. Cell type-dependent pro- and anti-inflammatory role of signal transducer and activator of transcription 3 in alcoholic liver injury. Gastroenterology. 2008;134:1148\u20131158","journal-title":"Gastroenterology"},{"key":"9701_CR67","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/hep.24517","volume":"54","author":"AMWH Miller","year":"2011","unstructured":"Miller AMWH, Bertola A, et al. Inflammation-associated IL-6\/STAT3 activation ameliorates alcoholic and nonalcoholic fatty liver diseases in IL-10 deficient mice. Hepatology. 2011;54:846\u2013856","journal-title":"Hepatology"},{"key":"9701_CR68","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1002\/hep.24599","volume":"54","author":"P Mandrekar","year":"2011","unstructured":"Mandrekar P, Ambade A, Lim A, Szabo G, Catalano D. An essential role for monocyte chemoattractant protein-1 in alcoholic liver injury: regulation of proinflammatory cytokines and hepatic steatosis in mice. Hepatology. 2011;54:2185\u2013197","journal-title":"Hepatology"},{"key":"9701_CR69","doi-asserted-by":"publisher","first-page":"3476","DOI":"10.1172\/JCI60777","volume":"122","author":"J Petrasek","year":"2012","unstructured":"Petrasek J, Bala S, Csak T, Lippai D, Kodys K, Menashy V, et al. IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice. J Clin Invest 2012;122:3476\u20133489","journal-title":"J Clin Invest"},{"key":"9701_CR70","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1172\/JCI24282","volume":"115","author":"R Bataller","year":"2005","unstructured":"Bataller R, Brenner DA. Liver fibrosis. J Clin Invest 2005;115:209\u2013218","journal-title":"J Clin Invest"},{"key":"9701_CR71","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","volume":"134","author":"SL Friedman","year":"2008","unstructured":"Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology. 2008;134:1655\u20131669","journal-title":"Gastroenterology"},{"key":"9701_CR72","doi-asserted-by":"publisher","first-page":"178","DOI":"10.4161\/oxim.3.3.12288","volume":"3","author":"M Setshedi","year":"2010","unstructured":"Setshedi M, Wands JR, Monte SM. Acetaldehyde adducts in alcoholic liver disease. Oxid Med Cell Longev 2010;3:178\u2013185","journal-title":"Oxid Med Cell Longev"},{"key":"9701_CR73","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1172\/JCI18212","volume":"112","author":"R Bataller","year":"2003","unstructured":"Bataller R, Schwabe RF, Choi YH, et al. NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis. J Clin Invest 2003;112:1383\u20131394","journal-title":"J Clin Invest"},{"key":"9701_CR74","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1038\/nm1663","volume":"13","author":"E Seki","year":"2007","unstructured":"Seki E, De Minicis S, Osterreicher CH, Kluwe J, Osawa Y, Brenner DA, et al. TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med 2007;13:1324\u20131332","journal-title":"Nat Med"},{"key":"9701_CR75","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1002\/hep.23739","volume":"52","author":"K Jagavelu","year":"2010","unstructured":"Jagavelu K, Routray C, Shergill U, et al. Endothelial cell toll-like receptor 4 regulates fibrosis-associated angiogenesis in the liver. Hepatology. 2010;52:590\u2013601","journal-title":"Hepatology"},{"key":"9701_CR76","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1002\/hep.21107","volume":"43","author":"V Purohit","year":"2006","unstructured":"Purohit V, Brenner DA. Mechanisms of alcohol-induced hepatic fibrosis: a summary of the Ron Thurman Symposium. Hepatology. 2006;43:872\u2013878","journal-title":"Hepatology"},{"key":"9701_CR77","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1055\/s-0029-1214376","volume":"29","author":"FJ Cubero","year":"2009","unstructured":"Cubero FJ, Urtasun R, Nieto N. Alcohol and liver fibrosis. Semin Liver Dis 2009;29:211\u2013221","journal-title":"Semin Liver Dis"},{"key":"9701_CR78","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1002\/hep.21664","volume":"46","author":"PJ Pockros","year":"2007","unstructured":"Pockros PJ, Schiff ER, Shiffman ML, et al. Oral IDN-6556, an antiapoptotic caspase inhibitor, may lower aminotransferase activity in patients with chronic hepatitis C. Hepatology. 2007;46:324\u2013329","journal-title":"Hepatology"},{"key":"9701_CR79","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/j.1365-2036.2010.04264.x","volume":"31","author":"ML Shiffman","year":"2010","unstructured":"Shiffman ML, Pockros P, McHutchison JG, et al. Clinical trial: the efficacy and safety of oral PF-03491390, a pancaspase inhibitor\u2014a randomized placebo-controlled study in patients with chronic hepatitis C. Aliment Pharmacol Ther 2010;31:969\u2013978","journal-title":"Aliment Pharmacol Ther"},{"key":"9701_CR80","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1016\/S0168-8278(10)60086-4","volume":"52","author":"V Ratziu","year":"2010","unstructured":"Ratziu V, Chojkiet M, Sheikh M, et al. Safety, tolerability and preliminary activity of GS-9450, a selective caspase inhibitor, in patients with non-alcoholic steatohepatitis. J Hepatol 2010;52:S38","journal-title":"J Hepatol"},{"key":"9701_CR81","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1080\/00952990701407702","volume":"17","author":"SK Ramaiah","year":"2007","unstructured":"Ramaiah SK, Jaeschke H. Hepatic neutrophil infiltration in the pathogenesis of alcohol-induced liver injury. Toxicol Mech Methods 2007;17:431\u2013440","journal-title":"Toxicol Mech Methods"},{"key":"9701_CR82","first-page":"1156","volume":"24","author":"J Maltby","year":"1996","unstructured":"Maltby J, Wright S, Bird G, et al. Chemokine levels in human liver homogenates: associations between GRO alpha and histopathological evidence of alcoholic hepatitis. Hepatology. 1996;24:1156\u20131160","journal-title":"Hepatology"},{"key":"9701_CR83","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/hep.22680","volume":"49","author":"A Lemmers","year":"2009","unstructured":"Lemmers A, Moreno C, Gustot T, et al. The interleukin-17 pathway is involved in human alcoholic liver disease. Hepatology. 2009;49:646\u2013657","journal-title":"Hepatology"},{"key":"9701_CR84","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1053\/j.gastro.2006.12.036","volume":"132","author":"J Colmenero","year":"2007","unstructured":"Colmenero J, Bataller R, Sancho-Bru P, et al. Hepatic expression of candidate genes in patients with alcoholic hepatitis: correlation with disease severity. Gastroenterology. 2007;132:687\u2013697","journal-title":"Gastroenterology"},{"key":"9701_CR85","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1053\/j.gastro.2009.01.056","volume":"136","author":"M Dominguez","year":"2009","unstructured":"Dominguez M, Miquel R, Colmenero J, et al. Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis. Gastroenterology. 2009;136:1639\u20131650","journal-title":"Gastroenterology"},{"key":"9701_CR86","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.jhep.2006.04.013","volume":"45","author":"D Seth","year":"2006","unstructured":"Seth D, Gorrell MD, Cordoba S, et al. Intrahepatic gene expression in human alcoholic hepatitis. J Hepatol 2006;45:306\u2013320","journal-title":"J Hepatol"},{"key":"9701_CR87","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1053\/j.gastro.2012.09.008","volume":"143","author":"P Kubes","year":"2012","unstructured":"Kubes P, Mehal WZ. Sterile inflammation in the liver. Gastroenterology. 2012;143:1158\u20131172","journal-title":"Gastroenterology"},{"key":"9701_CR88","doi-asserted-by":"publisher","first-page":"22672","DOI":"10.1074\/jbc.M114.552141","volume":"289","author":"X Ge","year":"2014","unstructured":"Ge X, Antoine DJ, Lu Y, et al. High mobility group box-1 (HMGB1) participates in the pathogenesis of alcoholic liver disease (ALD). J Biol Chem 2014;289:22672\u201322691","journal-title":"J Biol Chem"},{"key":"9701_CR89","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1159\/000324281","volume":"28","author":"G Szabo","year":"2010","unstructured":"Szabo G, Bala S, Petrasek J, Gattu A. Gut-liver axis and sensing microbes. Dig Dis 2010;28:737\u2013744","journal-title":"Dig Dis"},{"key":"9701_CR90","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s12263-009-0151-4","volume":"5","author":"EVM Albano","year":"2010","unstructured":"Albano EVM. Immuno mechanisms in alcoholic liver disease. Genes Nutr 2010;5:141\u2013147","journal-title":"Genes Nutr"},{"key":"9701_CR91","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/S0891-5849(01)00757-2","volume":"32","author":"E Mottaran","year":"2002","unstructured":"Mottaran E, Stewart SF, Rolla R, et al. Lipid peroxidation contributes to immune reactions associated with alcoholic liver disease. Free Radic Biol Med 2002;32:38\u201345","journal-title":"Free Radic Biol Med"},{"key":"9701_CR92","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1055\/s-2004-832940","volume":"24","author":"GM Thiele","year":"2004","unstructured":"Thiele GM, Freeman TL, Klassen LW. Immunologic mechanisms of alcoholic liver injury. Semin Liver Dis 2004;24:273\u2013287","journal-title":"Semin Liver Dis"},{"key":"9701_CR93","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1111\/j.1530-0277.2010.01309.x","volume":"34","author":"GM Thiele","year":"2010","unstructured":"Thiele GM, Duryee MJ, Willis MS, et al. Autoimmune hepatitis induced by syngeneic liver cytosolic proteins biotransformed by alcohol metabolites. Alcohol Clin Exp Res 2010;34:2126\u20132136","journal-title":"Alcohol Clin Exp Res"},{"key":"9701_CR94","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/hep.24018","volume":"53","author":"AW Yan","year":"2011","unstructured":"Yan AW, Fouts DE, Brandl J, Starkel P, Torralba M, Schott E, et al. Enteric dysbiosis associated with a mouse model of alcoholic liver disease. Hepatology. 2011;53:96\u2013105","journal-title":"Hepatology"},{"key":"9701_CR95","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.alcohol.2008.08.006","volume":"42","author":"IA ProKirpich","year":"2008","unstructured":"ProKirpich IA, Solovieva NV, Leikhter SN, Shidakova NA, Lebedeva OV, Sidorov PI, et al. Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study. Alcohol 2008;42:675\u2013682","journal-title":"Alcohol"},{"issue":"203\u2013214","key":"9701_CR96","first-page":"e16","volume":"148","author":"P Chen","year":"2015","unstructured":"Chen P, Torralba M, Tan J, Embree M, Zengler K, Starkel P, et al. Supplementation of saturated long-chain fatty acids maintains intestinal eubiosis and reduces ethanol-induced liver injury in mice. Gastroenterology. 2015;148(203\u2013214):e16","journal-title":"Gastroenterology"},{"key":"9701_CR97","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1002\/jcp.21172","volume":"213","author":"GK Michalopoulos","year":"2007","unstructured":"Michalopoulos GK. Liver regeneration. J Cell Physiol 2007;213:286\u2013300","journal-title":"J Cell Physiol"},{"key":"9701_CR98","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1053\/gast.1997.v112.pm9178701","volume":"112","author":"K Saso","year":"1997","unstructured":"Saso K, Moehren G, Higashi K, et al. Differential inhibition of epidermal growth factor signaling pathways in rat hepatocytes by long-term ethanol treatment. Gastroenterology. 1997;112:2073\u20132088","journal-title":"Gastroenterology"},{"issue":"1231\u20139","key":"9701_CR99","first-page":"e1","volume":"146","author":"J Altamirano","year":"2014","unstructured":"Altamirano J, Miquel R, Katoonizadeh A, Abraldes JG, Duarte-Rojo A, Louvet A, et al. A histologic scoring system for prognosis of patients with alcoholic hepatitis. Gastroenterology. 2014;146(1231\u20139):e1\u2013e6","journal-title":"Gastroenterology"},{"key":"9701_CR100","doi-asserted-by":"crossref","unstructured":"Dubuquoy L, Louvet A, Lassailly G, Truant S, Boleslawski E, Artru F, et al. Progenitor cell expansion and impaired hepatocyte regeneration in explanted livers from alcoholic hepatitis. Gut 2015;64:1949\u20131960","DOI":"10.1136\/gutjnl-2014-308410"},{"key":"9701_CR101","doi-asserted-by":"crossref","unstructured":"Rubbia-Brandt L, Lin-Marq N, Clement S, Frossard JL, Goossens N, et al. Hepatic cell proliferation plays a pivotal role in the prognosis of alcoholic hepatitis. J Hepatol 2015;63:609\u2013621","DOI":"10.1016\/j.jhep.2015.04.003"},{"key":"9701_CR102","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1002\/hep.25614","volume":"55","author":"P Sancho-Bru","year":"2012","unstructured":"Sancho-Bru P, Altamirano J, Rodrigo-Torres D, et al. Liver progenitor cell markers correlate with liver damage and predict short-term mortality in patients with alcoholic hepatitis. Hepatology. 2012;55:1931\u20131941","journal-title":"Hepatology"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-015-9701-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12072-015-9701-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-015-9701-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-015-9701-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T19:18:29Z","timestamp":1718479109000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12072-015-9701-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,12]]},"references-count":102,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["9701"],"URL":"https:\/\/doi.org\/10.1007\/s12072-015-9701-6","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"type":"print","value":"1936-0533"},{"type":"electronic","value":"1936-0541"}],"subject":[],"published":{"date-parts":[[2016,4,12]]},"assertion":[{"value":"29 October 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This work was supported by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) (1U01AA021908-01) and P30 DK34987.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding sources"}}]}}